LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT

被引：0
|
作者：
De la Rubia Navarro, M. [1 ]
Cortes, J. Ivorra [1 ]
Garcia, E. Grau [1 ]
Puig, L. Gonzalez [1 ]
Albuixech, R. Negueroles [1 ]
Cordellat, I. Martinez [1 ]
Ortiz-Sanjuan, F. [1 ]
Rodriguez, J. E. Oller [1 ]
Rodriguez, S. Leal [1 ]
Perales, C. Pavez [1 ]
Gil, J. J. Fragio [1 ]
Bernabeu, E. Vicens [1 ]
Barcena, C. Riesco [1 ]
Quispe, A. V. Huaylla [1 ]
Sanchez, L. Mas [1 ]
Munoz, P. [1 ]
Herranz, C. Najera [1 ]
Olmos, I. Canovas [1 ]
Ivorra, J. A. Roman [1 ]
机构：
[1] Hosp Univ La Fe, Reumatol, Valencia, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0435
引用
收藏
页码：1345 / 1346
页数：2
相关论文
共 50 条
  • [1] A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
    Rovin, Brad H.
    Furie, Richard
    Teng, Y. K. Onno
    Contreras, Gabriel
    Malvar, Ana
    Yu, Xueqing
    Ji, Beulah
    Green, Yulia
    Gonzalez-Rivera, Tania
    Bass, Damon
    Gilbride, Jennifer
    Tang, Chun-Hang
    Roth, David A.
    KIDNEY INTERNATIONAL, 2022, 101 (02) : 403 - 413
  • [2] Predicting decline of kidney function in lupus nephritis using urine biomarkers
    Abulaban, K. M.
    Song, H.
    Zhang, X.
    Kimmel, P. L.
    Kusek, J. W.
    Nelson, R. G.
    Feldman, H. I.
    Vasan, R. S.
    Ying, J.
    Mauer, M.
    Nelsestuen, G. L.
    Bennett, M.
    Brunner, H. I.
    Rovin, B. H.
    LUPUS, 2016, 25 (09) : 1012 - 1018
  • [3] Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
    Fava, Andrea
    Buyon, Jill
    Magder, Laurence
    Hodgin, Jeff
    Rosenberg, Avi
    Demeke, Dawit S.
    Rao, Deepak A.
    Arazi, Arnon
    Celia, Alessandra Ida
    Putterman, Chaim
    Anolik, Jennifer H.
    Barnas, Jennifer
    Dall'Era, Maria
    Wofsy, David
    Furie, Richard
    Kamen, Diane
    Kalunian, Kenneth
    James, Judith A.
    Guthridge, Joel
    Atta, Mohamed G.
    Trujillo, Jose Monroy
    Fine, Derek
    Clancy, Robert
    Belmont, H. Michael
    Izmirly, Peter
    Apruzzese, William
    Goldman, Daniel
    Berthier, Celine C.
    Hoover, Paul
    Hacohen, Nir
    Raychaudhuri, Soumya
    Davidson, Anne
    Diamond, Betty
    Petri, Michelle
    JCI INSIGHT, 2024, 9 (02)
  • [4] Reduction in Urinary CD163 Is Associated with Treatment Response in the Belimumab Lupus Nephritis Trial
    Weeding, Emma
    Fava, Andrea
    Mohan, Chandra
    Goldman, Daniel
    Petri, Michelle
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3619 - 3621
  • [5] Molecular imaging of the kidney in lupus nephritis to characterize response to treatment
    Parikh, Samir V.
    Malvar, Ana
    Song, Huijuan
    Alberton, Valeria
    Lococo, Bruno
    Vance, Jay
    Zhang, Jianying
    Yu, Lianbo
    Birmingham, Dan
    Rovin, Brad H.
    TRANSLATIONAL RESEARCH, 2017, 182 : 1 - 13
  • [6] New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab
    Staveri, Chrysanthi
    Karokis, Dimitrios
    Liossis, Stamatis-Nick C.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (06) : 788 - 790
  • [7] Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
    van Vollenhoven, Ronald F.
    Petri, Michelle A.
    Cervera, Ricard
    Roth, David A.
    Ji, Beulah N.
    Kleoudis, Christi S.
    Zhong, Z. John
    Freimuth, William
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (08) : 1343 - 1349
  • [8] URINE AND SERUM S100 PROTEINS ASSOCIATE WITH LUPUS NEPHRITIS AND RESPONSE TO TREATMENT
    Davies, J.
    Midgley, A.
    Donohue, S.
    Bruce, I. N.
    Beresford, M.
    Hedrich, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 348 - 348
  • [9] Urine Proteomic Classifiers Predict Renal Histological Activity and Chronicity Indices and May Predict Treatment Response in Lupus Nephritis
    Weeding, Emma
    Fava, Andrea
    Buyon, Jill
    Belmont, H. Michael
    Izmirly, Peter
    Clancy, Robert
    Monroy-Trujillo, Jose
    Fine, Derek
    Apruzzese, William
    Mischak, Harald
    Petri, Michelle
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] INCLUSION OF URINE SEDIMENT IN THE RESPONSE CRITERIA OF A LUPUS NEPHRITIS TRIAL UNDERMINES THE PROGNOSTIC VALUE OF PROTEINURIA IMPROVEMENT AS BEST PREDICTOR OF LONGTERM PRESERVATION OF RENAL FUNCTION: DATA FROM THE EURO-LUPUS NEPHRITIS TRIAL
    Houssiau, F. A.
    Mackay, M.
    Dall'Era, M.
    Wofsy, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 523 - 523
12345